Randomized Controlled Trial
Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.
J. Clin. Endocrinol. Metab. 2015 Feb 1;100(2):697-706.
Randomized Controlled Trial
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
J. Clin. Endocrinol. Metab. 2008 Jun 1;93(6):2149-57.
Randomized Controlled Trial
Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study.
J. Bone Miner. Res. 2015 Jan 1;30(1):39-45.